 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/06/2026 |
$4.39 |
$4.50 |
$4.30 |
$4.41 |
130.10K | | 07/07/2026 |
$4.42 |
$4.56 |
$4.18 |
$4.30 |
187.90K | | 07/08/2026 |
$4.17 |
$4.46 |
$4.09 |
$4.41 |
538.30K | | 07/09/2026 |
$4.44 |
$4.69 |
$4.44 |
$4.63 |
99.10K | | 07/10/2026 |
$4.62 |
$4.68 |
$4.28 |
$4.50 |
591.70K |
 |
| AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Its initial candidate is epetraborole, which is a potential once-daily, oral treatment with a novel mechanism of action for patients with non-tuberculous mycobacterial (NTM) lung disease, a rare, chronic, and progressive infectious disease caused by bacteria known as mycobacteria, which leads to irreversible lung damage and can be fatal. Epetraborole is designed to produce broad-spectrum antimycobacterial activity through inhibition of an essential and universal step in bacterial protein synthesis. | |
 |

AN2 Therapeutics (ANTX) has the following price history information. Looking back at ANTX historical stock prices for the last five trading days, on July 06, 2026, ANTX opened at $4.39, traded as high as $4.50 and as low as $4.30, and closed at $4.41. Trading volume was a total of 130.10K shares. On July 07, 2026, ANTX opened at $4.42, traded as high as $4.56 and as low as $4.18, and closed at $4.30. Trading volume was a total of 187.90K shares. On July 08, 2026, ANTX opened at $4.17, traded as high as $4.46 and as low as $4.09, and closed at $4.41. Trading volume was a total of 538.30K shares. On July 09, 2026, ANTX opened at $4.44, traded as high as $4.69 and as low as $4.44, and closed at $4.63. Trading volume was a total of 99.10K shares. On July 10, 2026, ANTX opened at $4.62, traded as high as $4.68 and as low as $4.28, and closed at $4.50. Trading volume was a total of 591.70K shares.
ANTX Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AN2 Therapeutics shares, starting with a $10,000 purchase of ANTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/25/2022 |
|
| End date: |
07/10/2026 |
|
| Start price/share: |
$15.40 |
|
| End price/share: |
$4.50 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-70.78% |
|
| Average Annual Total Return: |
-24.90% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,922.56 |
|
| Years: |
4.30 |
|
|
 |
| Date |
Close |
| 07/06/2026 | $4.41 | | 07/07/2026 | $4.30 | | 07/08/2026 | $4.41 | | 07/09/2026 | $4.63 | | 07/10/2026 | $4.50 |
|
 |